These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. False negative apraclonidine test in two patients with Horner syndrome. Kawasaki A, Borruat FX. Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417 [Abstract] [Full Text] [Related]
3. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY. Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593 [Abstract] [Full Text] [Related]
4. Using apraclonidine in diagnosing Horner syndrome in children. Sueke H, Chandna A. Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934 [No Abstract] [Full Text] [Related]
7. Topical apraclonidine in the diagnosis of suspected Horner syndrome. Freedman KA, Brown SM. J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427 [Abstract] [Full Text] [Related]
10. [Usefulness of apraclonidine in the diagnosis of Horner syndrome]. Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM. Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181 [Abstract] [Full Text] [Related]
11. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome. Nguyen MTB, Farahvash A, Zhang A, Micieli JA. J Neurol Sci; 2020 Dec 15; 419():117190. PubMed ID: 33075593 [Abstract] [Full Text] [Related]
12. Topical apraclonidine to diagnose Bernard-Horner syndrome. Kocabora M, Gocmez E, Taskapili M. Bull Soc Belge Ophtalmol; 2009 Dec 15; (312):9-15. PubMed ID: 19927485 [Abstract] [Full Text] [Related]
13. Exposure to topical apraclonidine in children with glaucoma. Wright TM, Freedman SF. J Glaucoma; 2009 Dec 15; 18(5):395-8. PubMed ID: 19525731 [Abstract] [Full Text] [Related]
14. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Brown SM, Aouchiche R, Freedman KA. Arch Ophthalmol; 2003 Aug 15; 121(8):1201-3. PubMed ID: 12912704 [No Abstract] [Full Text] [Related]
15. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Brown SM. Arch Ophthalmol; 2005 Apr 15; 123(4):578; author reply 578. PubMed ID: 15824244 [No Abstract] [Full Text] [Related]
16. Effect of 0.5% apraclonidine on ptosis in Horner syndrome. Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL. Ophthalmic Plast Reconstr Surg; 2006 Apr 15; 22(1):53-5. PubMed ID: 16418668 [Abstract] [Full Text] [Related]
17. False-negative apraclonidine testing in acute Horner syndrome. Dewan MA, Harrison AR, Lee MS. Can J Ophthalmol; 2009 Feb 15; 44(1):109-10. PubMed ID: 19169332 [No Abstract] [Full Text] [Related]
18. Possible effect of systemic sympathicolytic drugs on apraclonidine test. Martín-Moro JG, Botín DM, Muñoz-Negrete FJ. Can J Ophthalmol; 2009 Aug 15; 44(4):463; author reply 463-4. PubMed ID: 19606173 [No Abstract] [Full Text] [Related]
19. Early diagnosis of Horner syndrome using topical apraclonidine. Cooper-Knock J, Pepper I, Hodgson T, Sharrack B. J Neuroophthalmol; 2011 Sep 15; 31(3):214-6. PubMed ID: 21566530 [Abstract] [Full Text] [Related]
20. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. Br J Ophthalmol; 2005 Nov 15; 89(11):1442-4. PubMed ID: 16234449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]